Stem Cells and Regenerative Medicine

The regenerative medicine mainly uses stem cells to repair, replace, and regenerate tissues and organs affected by damage, disease, or ageing by restoring its normal function. These regenerative medicine market by the application are oncology, orthopaedic and musculoskeletal spine, wound healing, dermatology, neurodegenerative diseases, cardiovascular, and also in diabetes. The pluripotency and reprograming capability of stem cells increase the importance in this field. The global regenerative medicine market was valued at $5,444 million in 2016 and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. The factors driving the growth of the regenerative medicine market include the emergence of stem cell technology, rise in the incidence of degenerative diseases, and very fewer availability of organs for transplantation.

 

  • Embryonic stem cells
  • Tissue-specific Stem Cells
  • Mesenchymal stem cells
  • Induced pluripotent stem cells

Related Conference of Stem Cells and Regenerative Medicine

July 08-08, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
July 11-12, 2022

26th Global Congress on Biotechnology

Vienna, Austria
August 25-25, 2022

7th International Conference on Molecular Medicine and Diagnostics

Singapore City, Singapore
September 19-20, 2022

International Summit on Genomics and Proteomics

Dublin, Ireland
September 19-20, 2022

15th World Congress on Stem Cell Research

Dublin, Ireland
October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Stem Cells and Regenerative Medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in